Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Active not recruiting 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 3

Interventions

Pemetrexed 18Carboplatin 16Cisplatin 14Paclitaxel 9Gemcitabine 7pembrolizumab 6Crizotinib 5osimertinib 4amivantamab 4Nivolumab 4Docetaxel 4lazertinib 3Vinorelbine 3Ipilimumab 3Afatinib 3selpercatinib 2lorlatinib 2durvalumab 2cemiplimab 2atezolizumab 2alectinib 2Gefitinib 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2zenocutuzumab 1trastuzumab deruxtecan 1trametinib 1tepotinib 1telisotuzumab vedotin 1taletrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has announcements × Carcinoma, Non-Small-Cell Lung × lazertinib × Clear all
NCT02609776 2026-05-08

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting
751 enrolled 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04487080 2026-05-08

MARIPOSA

Janssen Research & Development, LLC

Phase 3 Active not recruiting
1,074 enrolled 13 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04988295 2026-05-08

MARIPOSA-2

Janssen Research & Development, LLC

Phase 3 Active not recruiting
776 enrolled 13 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡